More Investing
View Older Stories View Newer Stories-
Niagen Bioscience (NAGE) stock rises following positive clinical study
-
What are the three big things in markets now? RBC weighs in
-
Morgan Stanley downgrades Lululemon on weak US growth outlook
-
AppLovin would be more valuable without its 1P games, Morgan Stanley argues
-
London-listed Spectris soars 20% on fresh takeover interest from Advent
-
Tesla downgraded as 'uncertainty abounds'
-
Echostar stock sinks amid bankruptcy considerations
-
Warner Bros. Discovery to split into two media companies
-
Citi lifts S&P 500 target
-
Chevron CEO urged additional safety measures weeks before deadly Angola fire
-
UnitedHealth Group received multiple bids for Latin American operations
-
Macro strategist explains why it’s a good time to own Russell 2000
-
Tesla's (TSLA) Optimus program leader departs, autopilot head assumes role - Bloomberg
-
Carney launches ‘One Canadian Economy’ Act to unify trade, approvals
-
US job growth in May tops forecasts, but Macquarie warns cracks are emerging
-
U.S. Treasury, Commerce secretaries and Trade Representative to meet Chinese reps
-
BofA sees termination of Owens–Rotech deal as surprising but potentially positive
-
Neo Performance Materials stock surges on buyback plan
-
Goldman Sachs initiates coverage on generic drugmakers, sees upside in Teva and Am
-
Morgan Stanley upgrades Applied Materials on derisked outlook for China
-
Fed’s Harker says rate cuts this year still possible
-
General Motors (GM) appoints Mike Trevorrow SVP of Global Manufacturing
-
Phathom Pharmaceuticals shares soar on FDA exclusivity grant
-
Fed likely unmoved despite uneven May jobs report
-
Jefferies upgrades Urban Outfitters to Hold, says risk/reward now balanced
-
Melius upgrades Deere on long-term tech moat and recurring revenue upside
-
UAE’s data center project with U.S. tech firms faces security concerns
-
Taseko Mines shares surge on landmark agreement with Tŝilhqot’in Nation
-
Mosaic (MOS) shares fall on revised volume guidance
-
Citi upgrades Invitation Homes, downgrades American Homes 4 Rent on valuation gap
-
Trump urges Federal Reserve for a full point rate cut
-
Will Amazon’s robot delivery ambitions pay off?
-
Bernstein downgrades CrowdStrike on valuation, sees better upside in Palo Alto
-
Accuray (ARAY) stock tumbles on debt exchange concerns
-
Cibus (CBUS) stock rises on USDA deregulation of new canola trait
-
Berenberg downgrades OCI, says divestment cycle nearing end
-
U.S. adds 139,000 jobs in May
-
Shopify, Citi named signature picks at Wells Fargo
-
ZJK Industrial (ZJK) stock tumbles after retraction of production ramp-up announcement
-
Goldman Sachs lowers MYR Group, raises MasTec
-
Arvinas (ARVN) stock rises on FDA submission with Pfizer (PFE)
-
U.S. tariffs have implemented at a faster pace than expected - Danske Bank
-
ADI, TXN named top semiconductor picks by Citi
-
Virgin Galactic stock jumps on SpaceX competition speculation
-
Vera Therapeutics stock sinks following competitor’s successful trial
-
Goldman Sachs lowers Tesla vehicle delivery estimates
-
EMA says Ozempic, Wegovy may cause rare eye condition
-
Spirits outlook dims further amid tariffs, inventory shifts: Jefferies
-
Jefferies starts Excelerate Energy at Buy on LNG tailwinds and stable cash flow
-
Trump unlikely to drive down drug prices substantially: Capital Economics
